Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
136.99
+5.31 (+4.03%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,026,179
Open
131.35
Bid (Size)
136.05 (1)
Ask (Size)
139.37 (1)
Prev. Close
131.68
Today's Range
130.11 - 137.19
52wk Range
90.96 - 156.66
Shares Outstanding
158,600,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
November 20, 2024
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Performance
YTD
+2.34%
+2.34%
1 Month
-4.91%
-4.91%
3 Month
+5.92%
+5.92%
6 Month
+33.04%
+33.04%
1 Year
+44.05%
+44.05%
More News
Read More
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
November 05, 2024
Via
Benzinga
Looking Into Illumina's Recent Short Interest
November 04, 2024
Via
Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
November 04, 2024
Via
Benzinga
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
Via
Talk Markets
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,600 Today
October 28, 2024
Via
Benzinga
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
October 17, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,600 Today
October 16, 2024
Via
Benzinga
Decoding 14 Analyst Evaluations For Illumina
October 10, 2024
Via
Benzinga
How Is The Market Feeling About Illumina?
October 09, 2024
Via
Benzinga
Biotech Stocks Poised For Another Big Move In Q4
October 07, 2024
Via
Talk Markets
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
October 01, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $38,000 Today
September 11, 2024
Via
Benzinga
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
September 03, 2024
Via
Benzinga
Peering Into Illumina's Recent Short Interest
September 02, 2024
Via
Benzinga
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
August 28, 2024
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $47,000 Today
August 14, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 31
August 31, 2024
Via
Talk Markets
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
August 19, 2024
Via
Benzinga
This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
August 16, 2024
Via
Benzinga
Alibaba To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Friday
August 16, 2024
Via
Benzinga
This Starbucks Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
August 14, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.